Yayın:
Sorafenib-induced pancreatitis

Basit Görünüm
dc.contributor.authorAyyildiz, T.
dc.contributor.authorAydin, T.
dc.contributor.authorEminler, A.
dc.contributor.authorYildirim, C.
dc.contributor.authorIrak, K.
dc.contributor.authorKiyici, M.
dc.contributor.authorGurel, S.
dc.contributor.authorNak, S.
dc.contributor.authorGulten, M.
dc.contributor.authorDolar, E.
dc.contributor.buuauthorAydın, Taner
dc.contributor.buuauthorEminler, Ahmet Tarık
dc.contributor.buuauthorYıldırım, Çınar
dc.contributor.buuauthorIrak, Kader
dc.contributor.buuauthorKIYICI, MURAT
dc.contributor.buuauthorNAK, SELİM GİRAY
dc.contributor.buuauthorGÜLTEN, MACİT
dc.contributor.buuauthorDOLAR, MAHMUT ENVER
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.departmentGastroenteroloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-3208-6211
dc.contributor.scopusid56641035600
dc.contributor.scopusid24066287600
dc.contributor.scopusid56604790800
dc.contributor.scopusid37080733400
dc.contributor.scopusid6507627491
dc.contributor.scopusid7003706434
dc.contributor.scopusid6603336505
dc.contributor.scopusid6603629209
dc.contributor.scopusid6602075084
dc.date.accessioned2025-05-13T10:03:22Z
dc.date.issued2015-01-01
dc.description.abstractSorafenib is an inhibitor of multikinase proteins which is used for metastatic renal cell carcinoma and advanced stage hepatocellular carcinoma. Its side effects include serum amylase and lipase elevations anticipated to occur within first weeks of treatment but clinically and radiologically evident acute pancreatitis develops rarely. Five cases of acute pancreatitis have been reported in literature until date. The case we described here is the sixth case of clinically diagnosed acute pancreatitis.
dc.identifier.doi10.5835/jecm.omu.32.03.008
dc.identifier.endpage135
dc.identifier.issn1309-4483
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85006651454
dc.identifier.startpage133
dc.identifier.urihttps://hdl.handle.net/11452/52419
dc.identifier.volume32
dc.indexed.scopusScopus
dc.language.isoen
dc.publisherOndokuz Mayis Universitesi
dc.relation.journalJournal of Experimental and Clinical Medicine (Turkey)
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTyrosine kinase inhibitor
dc.subjectSorafenib
dc.subjectPancreatitis
dc.subjectHepatocellular carcinoma
dc.titleSorafenib-induced pancreatitis
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Gastroenteroloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı
local.indexed.atScopus
relation.isAuthorOfPublicationb364b52b-c416-4987-b080-93f6f81ecb3e
relation.isAuthorOfPublicationd10cf153-b88c-4394-bb90-1181ef8285aa
relation.isAuthorOfPublication4a56dde7-d229-487a-8cda-5bf4f57c0f7c
relation.isAuthorOfPublication9f100906-5262-4b98-9828-2958eac56d15
relation.isAuthorOfPublication.latestForDiscoveryb364b52b-c416-4987-b080-93f6f81ecb3e

Dosyalar

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications